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Abstract:  Domoic acid produced by marine algae has been shown to cause acute and 
chronic neurologic sequelae in Californian sea lions following acute or low-dose exposure. 
Histological findings in affected animals included a degenerative cardiomyopathy that was 
hypothesized  to  be  caused  by  over-excitation  of  the  glutamate  receptors  (GluRs) 
speculated to be present in the sea lion heart. Thus tissues from five sea lions without 
lesions associated with domoic acid toxicity and one animal with domoic acid-induced 
chronic  neurologic  sequelae  and  degenerative  cardiomyopathy  were  examined  for  the 
presence of GluRs. Immunohistochemistry localized mGluR 2/3, mGluR 5, GluR 2/3 and 
NMDAR 1 in structures of the conducting system and blood vessels. NMDAR 1 and GluR 
2/3  were  the  most  widespread  as  immunoreactivity  was  observed  within  sea  lion 
conducting system structures. PCR analysis, cloning and subsequent sequencing of the seal 
lion  GluRs  showed  only  80%  homology  to  those  from  rats,  but  more  than  95% 
homologous to those from dogs. The cellular distribution and expression of subtypes of 
GluRs in the sea lion hearts suggests that exposure to domoic acid may induce cardiac 
damage and functional disturbances. 
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1. Introduction  
Domoic  acid  is  a  potent  neurotoxic  analogue  of  the  naturally  occurring  excitatory  amino  acid  
L-glutamate. This toxin enters the marine food chain following production by several genera of marine 
algae  having  worldwide  distribution.  Domoic  acid  was  responsible  for  an  outbreak  of  amnesic 
shellfish  poisoning  (ASP)  in  1987  in  humans  [1–6].  The  syndrome  was  named  ASP  due  to  the 
confusion, loss of memory and disorientation that developed in affected people [2–5]. Subsequently, it 
has been shown to affect numerous organisms and causes mortality in a variety of species, including 
sea  birds,  marine  mammals  and  fish  [7,8–16].  The  common  neurological  signs  of  domoic  acid 
poisoning,  including  pruritus,  ataxia,  tremors  and  seizures,  have  been  documented  in  mice,  rats, 
cynomologus monkeys and Californian sea lions (Zalophus californianus) [1–3,5,6,13,14]. In addition 
to the neurologic effects, experimental exposure in laboratory animals and natural exposure in humans 
resulted in gastro-intestinal disturbances, cardiovascular arrhythmias and collapse [3,17–19].  
In 1998 and 2000, hundreds of free-ranging Californian sea lions, predominantly adult females, 
suffered from domoic acid toxicity during three harmful algal bloom events in central and northern 
California coastal waters. Heart pathology was reported in these acutely affected sea lions [8,11–13,15,16], 
and since then, a degenerative cardiomyopathy has been characterized in both males and females of all 
ages suffering from acute and chronic effects [16]. Gross pathology was non-specific and not present 
consistently. Histopathology was characterized by cardiomyocyte vacuolar degeneration and loss with 
adipocyte replacement that started at the base of the interventricular septum distal to the atrioventricular 
node  and  progressed  distally  and  circumferentially,  especially  in  the  mid-myocardium  to 
subendocardium.  The  features  of  the  degenerative  cardiomyopathy  were  not  consistent  with  other 
known causes of heart lesions in sea lions and were less consistent with a centrally-mediated (brain-
heart) mechanism. Thus, the cardiomyopathy was hypothesized to be caused by exposure to domoic 
acid activating the glutamate receptors that maybe present in the heart [16].  
There are two groups of glutamate receptors identified: (1) ionotropic glutamate receptors (iGluRs) 
that are fast-acting and (2) metabotropic glutamate receptors (mGluRs) that mediate more long-term 
cellular function. Ionotropic receptors contain integral cation-specific ion channels and are subdivided 
according to their selective agonists into (1) N-methyl-D-aspartate (NMDA), (2) -amino-3-hydroxy-
5-methyl-4-isoxazole-propionic  acid  (AMPA),  and  (3)  kainate  (Ka)  receptors.  Activation  of  these 
receptors  leads  to  the  opening  of  a  group  of  ion  channels  that  are  typified  by  their  different 
permeabilities  to  Na
+,  K
+,  and  Ca
2+  [20–22].  The  mGluRs  are  coupled  to  G-proteins  and  are 
subdivided according to agonist interactions and second messenger activation into (1) mGluR 1 and 5; 
(2)  mGluR  2  and  3;  and  (3)  mGluR  4,  6,  7  and  8.  Activation  of  these  receptors  modulate  the 
production of second messengers such as inositol phosphates and/or adenylate cyclase [3,21–23]. The 
potential toxic effects of glutamate and its analogues are not limited to the brain, as a recent review of 
the anatomical distribution of glutamate receptors demonstrated their presence in peripheral tissues, 
including the heart [3,17,18,24]. Also, there is accumulating evidence that GluRs mediate excitatory 
neurotransmission in peripheral neural and non-neural tissues and are involved in various organ/tissue 
functions and pathologies [17–19].  
The objectives of this paper were to: (a) demonstrate the cell specific presence of the different 
subtypes of the glutamate receptors (GluRs) in sea lion heart using immunochemical methods; (b) to Mar. Drugs 2010, 8                             
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clone  and  sequence  these  GluRs;  and  (c)  to  ascertain  whether  the  GluRs  were  involved  in  the 
cardiomyopathy using expression profiles for different subtypes of GluRs.  
2. Results  
Immunohistochemistry was performed on formalin-fixed archived heart tissues obtained from two 
control animals. Antibodies anti-GluR 2/3, anti-NMDAR 1, anti-mGluR 2/3 and anti-mGluR 5 were 
used and all four were immunoreactive with the bundle of His and the nerve fibres (Figure 1A to 
Figure 1B). The AV node and ganglia cells were immunoreactive for anti-NMDAR 1 and anti-GluR 
2/3  antibodies.  Cardiac  blood  vessels  were  immunoreactive  for  the  four  antibodies.  Anti-Ka-2 
antibody did not provide specific immunoreactivity at any dilution. 
Figure 1. Photomicrographs of the heart tissue from animal No. 1 stained with polyclonal 
antibodies for glutamate receptors in microwaved paraffin sections (A). GluR 2/3 (0.008 µ g/mL) 
and (B). NMDA R1 (0.01 µ g/mL) both staining the bundle of His and nerve fibers.  
 
 
Molecular analysis was performed on RNA extracted from frozen heart tissues from three different 
control  animals  and  from one heart  obtained  from a  sea lion suffering  from chronic effects  from 
previous domoic acid toxicity showing both brain and heart pathology. Using primer pairs designed 
from several regions of the rat glutamate receptor subtypes, PCR conditions were optimized for each 
receptor using the RNA obtained from the rat heart. The correct amplified products were obtained. 
However, using these same conditions and the same primers, no PCR products were obtained using 
either total RNA or mRNA obtained from the sea lion hearts.  
Hence, an alternate strategy had to be devised to clone the GluRs from the heart of sea lions for 
expression analysis. Three different primer sets (Table 1) were designed and synthesized from various 
conserved domains by aligning (using ClustalW2) the cDNA sequences of the dog, human, rat and 
mouse available from GenBank. Cloning of these receptors was only done from the rat, human and the 
seal lion. Using the PCR primers, the correct PCR fragments were obtained for all these three species. 
These  fragments  were  all  extracted  from  the  agarose  gel  and  cloned  into  the  PCR2.1-TOPO  
TA-cloning vector. The clones corresponding to Ka-2, NMDAR 1, GluR 1, GluR 6 and mGluR 5 from 
all three species were sequenced. All sequences obtained from the clones corresponding to the rat and 
human samples were 100% homologous to their counterparts. The clones obtained from the sea lion 
hearts showed varying amounts of homology to the GluRs of the dog and the rat. NMDAR-1 (Figure 
2) was 94% homologous to the dog (Canis lupus familiaris lupus; NM_001008717.1) and only 88% to Mar. Drugs 2010, 8                             
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the  rat  (Rattus  norvegicus;  NM_017010.1).  GluR  1  (Figure  3)  was  97%  homologous  to  the  dog  
(Canis lupus familiaris lupus; XM_546286.2) and 88% to the rat (Rattus norvegicus; NM_031608.1). 
The GluR 6 (Figure 4) was 97% homologous to the dog (Canus lupus familiaris lupus; XM_539059.2) 
and 92% to the rat (Rattus norvegicus; NM_019309.2).  
Sequences corresponding to mGluR 5 were not obtained from sea lion tissues;  however, those 
obtained from both rat and human RNA aligned with their respective sequences. For the Ka-2 receptor, 
several different size clones were obtained. All clones and the PCR fragment, which was extracted 
from the agarose gel, were sequenced. The clones showed varying homology to the Ka-2 sequence in 
GenBank. However, when the PCR product was extracted from the agarose gel and sequenced, the 
sequence was 100% homologous to the Ka-2 receptor of the mouse (Mus musculus; NM_008168.2) 
and the rat (Rattus norvegicus; NM_031508.2). This suggests that during the cloning process, the PCR 
fragment underwent rearrangement in the bacterial host [25]. 
Table  1.  Primers  designed  for  cloning  the  subtypes  of  Glutamate  Receptors  from  the 
Californian Sea Lion (Zalophus californianus). 
Gene of 
interest 
Forward Primer  Reverse Primer 
Expected 
fragment size 
GluR 6  GGACTAAACCTGGCTATGAC  CATGCAGCAAGGTTCTGAGC  840 bp 
Kainate 
Ka 2 
GCACATGGGCCGCAAGC  CAGCAATGATGAGGCCACAG  875 bp 
GluR 1  GTTCCCAGTTCTCCAAAGGAG 
R1-CAT TCC AGT AAC CGA TCT 
TTC GG 
R2-CAT TCC AGT AAC CAA TCT 
TTC GG 
927 bp 
mGluR 5   CTTCAGGCGAAGCATGAAG  GGTGGCGGCAGCGGATG  947 bp 
NMDAR 1  CTAGCCAGGTCTACGCTATC   CTGGGAATCTCCTTCTTGACC   1393 bp 
Note: For GluR 1, equimolar of the Reverse primers R1 and R2 were used. 
Figure 2. Sequence of the 1393bp fragment of the NMDAR 1 receptor from Californian sea lions. 
CCCAACGACCACTTCACTCCCACCCCCGTCTCCTACACAGCCGGCTTCTA 
CCGCATCCCCGTCCTGGGGCTGACCACCCGTATGTCCATCTATTCAGACA 
AGAGCATACACCTGAGCTTCCTTCGCACGGTGCCGCCCTACTCCCACCAG 
TCCAGTGTGTGGTTCGAGATGATGCGCGTCTACAGCTGGAACCACATCAT 
CCTCCTGGTCAGCGACGACCACGAAGGCAGGGCCGCGCAGAAGCGCCTGG 
AGACGCTGCTGGAGGAGCGCGAGTCCAAGAGTAAAAAAAGGAACTATGAA 
AACCTCGACCAACTGTCCTATGACAACAAGCGCGGACCCAAGGCTGAGAA 
GGTGCTGCAGTTCGACCCGGGGACCAAGAATGTGGCGGCCCTGCTGATGG 
AGGCGCGGGAGCTGGAGGCCCGGGTCATCATCCTCTCTGCCAGCGAGGAC 
GATGCTGCCACCGTGTACCGCGCAGCCGCGATGCTGAACATGACCGGCTC 
CGGGTACGTGTGGCTGGTGGGGGAGCGCGAGATCTCAGGCAACGCTCTGC 
GCTACGCCCCGGATGGCATCATCGGACTGCAGCTCATCAATGGCAAGAAC Mar. Drugs 2010, 8                             
 
1641 
GAGTCAGCGCACATCAGCGACGCCGTGGGCGTCGTGGCCCAGGCAGTGCA 
TGAACTCCTGGAGAAGGAGAACATCACCGACCCGCCCCGGGGCTGCGTGG 
GCAATACCAACATCTGGAAGACGGGGCCGCTCTTCAAGAGAGTGCTGATG 
TCTTCCAAGTATGCAGACGGGGTGACAGGCCGCGTGGAGTTCAATGAGGA 
TGGGGATCGGAAGTTTGCTAACTACAGCATCATGAACCTGCAAAACCGGA 
AGCTGGTGCAAGTGGGCATCTACAACGGCACCCATGTCATCCCCAATGAC 
AGGAAGATCATTTGGCCAGGTGGAGAGACAGAGAAGCCCCGAGGGTACCA 
GATGTCCACCAGGCTGAAGATTGTGACGATCCATCAGGAGCCTTTCGTGT 
ACGTCAAGCCCACGCTGAGCGATGGCACATGCAAGGAGGAGTTCACCGTC 
AATGGGGACCCGGTCAAGAAAGTGATCTGCACTGGACCCAACGACACGTC 
GCCAGGCAGCCCTCGCCACACAGTGCCTCAGTGCTGCTACGGCTTCTGCA 
TCGATCTGCTCATCAAGCTGGCGCGCACCATGAACTTCACCTACGAGGTG 
CACCTGGTGGCTGATGGCAAGCTCGGCACTCAAGAGCGGGTGAACAACAG 
CAATAAGAAGGAGTGGAATGGGATGATGGGCGAGCTGCTCAGCGGGCAGG 
CGGACATGATCGTGGCGCCGCTGACCATCAACAACGAGCGTGCACAGTAC 
ATCG 
Figure 3. Sequence of the 927 bp fragment of the GluR 1 receptor from Californian sea lions. 
CCATCTTTGGGTTTTATGAACGGAGAACTGTCAACATGCTGACCTCCTTC 
TGTGGGGCCCTCCACGTCTGCTTCATTACACCGAGCTTTCCCGTTGACAC 
CTCCAATCAGTTTGTCCTTCAGCTGCGCCCTGAGCTGCAGGATGCTCTTA 
TCAGCATCATCGACCATTACAAGTGGCAGAAATTTGTCTACATTTATGAT 
GCCGACCGGGGTCTGTCCGTCCTGCAGAAAGTCCTGGACACAGCTGCCGA 
GAAGAACTGGCAGGTGACAGCAGTCAACATTTTAACCACCACAGAGGAGG 
ATACCGGATGCCCTTTCAGGACCTGGAAAAGAAAAAGGAGCGGCTAGTGG 
TTGTGGACTGTGAATCAGAACGCCTCAATGCCATCTTGGGCCAGATCATA 
AAGCTGGAGAAGAACGGCATCGGCTACCACTACATCCTTGCAAATCTGGG 
TTTCATGGATATTGACTTAAACAAATTCAAGGAGAGTGGAGCAAATGTTA 
CAGGTTTCCAGTTGGTGAACTACACAGACACCATCCCAGCCAAAATCATA 
CAGCAGTGGAAGAATAGCGATGCTCGAGACCACACCCGAGTGGACTGGAG 
GAGACCTAAGTACACCTCTGCGCTCACCTACGATGGAGTGAAGGTGATGG 
CTGAGGCTTTTCAGAGCCTGCGGAGGCAGAGAATCGATATATCCCGCCGA 
GGGAATGCTGGGGACTGCCTGGCTAACCCAGCTGTGCCGTGGGGCCAGGG 
GATCGACATCCAGAGAGCGCTGCAGCAGGTGCGGTTTGAAGGCTTGACAG 
GAAACGTGCAGTTTAATGAGAAGGGACGCCGGACCAACTACACTCTCCAT 
GTGATTGAAATGAAGCATGATGGCATCCGAAAGATTGG 
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Figure 4. Sequence of the 840bp fragment of the GluR 6 receptor from Californian sea lions. 
CTCACTATAGGGCGAATTGGGCCCTCTAGATGCATGCTCGAGCGGCCGCC 
AGTGTGATGGATATCTGCAGAATTCGGCTTGGACTAAACCTGGCTATGAC 
AAAGAGCACACAACTGACACCCAAGTAAGCCAGCAGAATATACATCCAGA 
TATCAGGGGAGAGAGGATTCAGGAAGGAGAAGACGCCTGGGTTTGTACCA 
TTGGGCTTGCGGTACAAAATACTTATTCCAAGTGTCATAAAGGGCTTGGA 
AAAGTCGGTGACCTTCTCTCGAACGTAGGTAATAGCCAGTGGGGCAACTG 
CAAGGTCAGCTTTATGATCAATCAGTTCACGGACCATTCCATTCCACTGT 
CCATTGGCATCATCCTGAGCTCCGTATTTCCCATCCTCCACAAGTCTAAT 
TTCATATGTAAAGCCAAGGATTGTAGATAACTCTCTGAGGAGGTCAATGC 
AATAGCCCTCAAATCGATCATTCCCATAGAGAGGCTTGTCAGATTTCTTA 
AACAGGACATAGGGTTCTTCCAAAATGGTGGTAACGATCAAAGAACGATT 
AGATAAGGAGTCTGTGATGTTGGTTGGCTTTCCCTTTTGACTTTCTGTCA 
TATTCAGGCCACTGGCTGGATCCCAAGTTCCAATCTTTTCCAAACCTTCT 
TCTTTGAGGCTGATCACATCCAAATCAAAATCTGTTCGTAAGCCATTGGT 
TTTGTTGAAAGTTATTCTGCCTGTGAGACCTTCCCAATGTGCCTCTTTAA 
TTAGGCTCATAAAACGGGTCCCGAAGCGCCAGGGTTTGTGTCTATTACAC 
TGTAAGGAGCTGACTGTCATCTGGGGAAACTGTTGGACG 
Figure 5. Sequence of the 875 bp fragment of the kainite receptor Ka-2 from Californian sea lions. 
GAGCTGCAGGATGGCCAGTGTGATCTCATCCCGGAAAGGGGAGCCCAGCG 
GCATGCCGATGCCGTAGCCCTTGGTGTCGAGGAGGCCCCCGATCTGGGTG 
AGGTTGCAATTGAGGCGCCTGTGGTACTCGTTCATGGTGGACTCCAGCAG 
GAAGGCATAGCGGGAGTTGAGGACGCGGGCGATTCCCTCCTCTGTGCTCT 
TGACAAACACGCTGGGCTGCTTCGATTGCATGTAGTTCCACATCCGCTGG 
TACGTCTGGTACCGCGAGTTCTGGAAGAAGGTCATGGTGGAGCCAGCGTG 
GATAGTGCCGTACTCAATGTTGGTCTGATCCGCCAGGTCGTCAGCCGACT 
CCACCGGCACCTCCATGCGCTGCACCGTGAGGAAGGCAGCCAGGTTGGCC 
GTGTAGGAGGAGATGATGATCAAGGTGAAGGCCCACCAGACTCCGCTGAC 
ACAGCGTGTGGACAGTGCCCGCGGCATGATCTCCGAGCCCTGCTGCATGA 
AGCCACCCACGGGGAACCAGAGGCTGTTGCCCAGCGTGTACTGGTTCTCC 
AGGATATGGGGACGCGCCCGGAGACACGGGTGTGGGTTGTACCACTCATA 
AGGGCTCAGCCTGGCAGCCAGGAACAAGACACAGCTGACAGCCAGGTAGG 
CAAGAAGCATGAAGAGCCACAC 
3. Expression Analysis 
PCR fragments for GluR 1 and GluR 6 were examined to compare levels of expression between the 
three control animals and one domoic acid-affected animal. Although both receptors were expressed in 
the left and right ventricles of the heart from each animal, there was varying amounts of expression 
among the control animals for both subtypes. Figure 6 shows the level of expression of GluR 6 for Mar. Drugs 2010, 8                             
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three different control animals (lanes 2–4) and one domoic acid-affected animal (lane 5). There was 
varying amounts of expression (as observed by the intensity of the PCR fragments in the agarose gel) 
among the control animals. This illustrates the inter-individual variation among the control animals 
and domoic acid-affected animal.  
Figure  6.  Agarose  gel  (1%)  image  showing  results  from  the  PCR  fragment  of  the 
glutamate receptor subtype GluR 6. Lanes 2, 3, and 4 correspond to the PCR fragments 
obtained  from  control  animals,  and  lane  5  corresponds  to  one  domoic  acid  affected 
Californian sea lion. Lane 1 corresponds to the molecular weight marker. The size of the 
PCR product is approximately 840 base pairs. 
 
4. Discussion 
In the CNS, GluRs have been shown to be the mediators for excitotoxic effects of excitatory amino 
acids (EAAs) and/or their structural analogues such as domoic acid. Although these receptors were 
once thought to be predominantly located in the CNS, recent evidence shows that they are also present 
in peripheral neural and non-neural tissues [17–19,24]. These GluRs in peripheral tissues are potential 
targets for the toxic effects of EAAs present in foods and the environment [17–19,24]. The association 
of  arrhythmias  and  other  cardiovascular  symptoms  in  humans  intoxicated  with  DA  and  on  
individuals susceptible to MSG prompted us to focus our attention to the investigation of GluRs in 
heart [1,3,17–19,24]. We have hypothesized that GluRs play a role in mediating the cardiac effects of 
these  glutamate  analogues.  Hence,  the  observation  of  degenerative  cardiomyopathy  in  sea  lions 
intoxicated with DA further supports the view that DA may be cardiotoxic [3,4,16,18,19]. 
In order to determine whether the glutamate receptors were directly involved in the pathogenesis of 
the  degenerative  cardiomyopathy,  the  GluRs  were  localized  to  specific  cellular  structures  using 
immunochemical methods. Antibodies to GluR 2/3, NMDAR 1, mGluR 2/3 and mGluR 5 were all 
immunoreactive with the bundle of His, the nerve fibres and the cardiac blood vessels. NMDAR 1 and 
GluR 2/3 were found in the AV node and ganglia in the hearts obtained from both normal sea lions and 
an animal showing degenerative cardiomyopathy. This specific cellular localization of GluRs to the 
different components of the conducting system supports that these receptors may play a role in cardiac 
physiology, and in particular may be involved in pathogenesis of the degenerative cardiomyopathy as a 
direct result of the over-excitation of GluRs in heart tissue. This is supported by the fact that the Mar. Drugs 2010, 8                             
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distribution of the cardiomyopathy was distal to the AV node and in close proximity to the major 
conducting  system  structures  and  often  small  to  medium-sized  blood  vessels.  From  our 
immunohistochemistry data, these are the same regions in which the GluRs were localized. Domoic 
acid is known to exert its neurotoxic effects by binding primarily the NMDA, GluRs in the central 
nervous  system  causing  increased  intracellular  calcium  and  eventually  neuronal  death  through 
apoptosis [17,23,26]. Recent in vitro studies provide evidence suggesting that stimulation of NMDA 
GluRs  in  the  cardiomyocytes  may  lead  to  apoptosis  via  a  Ca
2+,  ROS,  and  caspase-3  mediated  
pathway [24,26]. This mechanism is consistent with the morphology of the cardiomyopathy, which 
had features of apoptosis, and cardiomyocytes immunoreactive to caspase-3 antibody [16]. Thus, these 
findings in conjunction with the clinical manifestation of unstable blood pressure and arrhythmias in 
humans with ASP and laboratory animals experimentally exposed to domoic acid [3–6,17,27] strongly 
suggest a functional role for these receptors in the heart. Zabka et al. [16] showed that severity of 
domoic acid-induced brain lesions and death did not always correlate in some sea lions, and thus 
suggested  that  the  cardiomyopathy  may  be  associated  with  functional  cardiac  disturbances  that  
could be fatal. 
In addition to the immunochemical localization of the glutamate receptors we performed expression 
profiles of two subtypes of glutamate receptors, GluR 1 and GluR 6 in three control sea lions and one 
domoic acid affected animal. As there was inter-individual variation in expression for both GluRs in 
the control animals and the domoic acid affected animal, it could not be ascertained if the GluRs were 
involved  in  cardiomyopathy.  Hence,  a  larger  number  of  tissues  from  both  control  and  domoic  
acid-affected  animals  must  be  analyzed  in  order  to  correlate  changes  in  expression  with  the 
distribution of the receptor subtypes.  
5. Experimental Section  
5.1. Materials and Methods 
Tissues  and  sections  were  obtained  from  Californian  sea  lions  that  died  while  undergoing 
rehabilitation  at  The  Marine  Mammal  Center,  Sausalito,  CA,  USA.  The  control  animals  were 
euthanized while undergoing rehabilitation as a result of trauma, blindness or severe eye disease. The 
designation  of  ―control‖  was  based  on  the  lack  of  domoic  acid-associated  ante-  or  post-mortem 
findings, as the history of domoic acid exposure in free living sea lions is unknown. The domoic acid 
affected  animal  was  a  juvenile  male  that  restranded  within  a  month  of  initial  release  following 
diagnosis and treatment for long term effects from previous exposure to domoic acid. This animal was 
euthanized shortly following readmission due to persistent neurologic disease. Gross and histological 
examination  showed  hippocampal  atrophy  consistent  with  exposure  to  domoic  acid  and  also 
demonstrated a mild, acute degenerative cardiomyopathy.  
5.2. Tissue Preparation and Immunohistochemistry 
Immunohistochemistry for various subtypes of GluRs was performed on formalin-fixed archived 
samples of hearts to demonstrate their presence and distribution. The regions of heart examined were 
the  mid-ventricle  with  distal  bundle  branches  and  peripheral  nerves,  subvalvular  to  the  right Mar. Drugs 2010, 8                             
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atrioventricular (AV) valve with proximal bundle branches and peripheral nerves, and right AV valve 
with AV node and the Bundle of His. Tissues were embedded in paraffin and sections (4–5 μm) were 
mounted on silinated slides. The sections were deparaffinized and passed through a series of 100% 
ethanol. Slides were placed in 10 mM sodium citrate buffer (pH 6.0) and microwaved for antigen 
retrieval for two 3-minute periods at 450 W with gentle agitation (Kenmore 900 W or H2200/Energy 
Beam Science Inc.). Microwave-treated sections were washed in phosphate buffered saline (PBS) and 
blocked for endogenous avidin and biotin in a 0.5% hydrogen peroxide/100% ethanol solution. Slides 
were rinsed in 95% ethanol and then in running distilled water [18,19,24]. Immunohistochemistry was 
performed using the avidin-biotin method and the following primary polyclonal antibodies: NMDAR-1 
(0.01 ug/mL; Chemicon International Inc., Temecula, CA, USA), anti-mGluR 5 (0.05 ug/mL; Chemicon 
International Inc.), anti-GluR 2/3 and anti-mGluR 2/3 (0.008 and 0.01 ug/mL, respectively; Chemicon 
International Inc.), and anti-Ka-2 (Upstate Biotechnology Inc., New York, USA). To obtain the optimal 
dilutions, a series of primary antibody dilutions, which ranged from 0.0005 to 0.02 μg/μL and were made 
in 15% normal swine serum [18,19,24]. After washing in PBS, slides were then incubated at room 
temperature  in  biotinylated  F(ab')  swine-anti-rabbit  secondary  antibody  (Dako  Canada,  Inc., 
Mississauga,  ON,  Canada)  diluted  in  15%  normal  serum.  The  slides  were  washed  again  in  PBS, 
followed  by  an  incubation  of  30  min  at  room  temperature  in  streptavidin  (1:200)  complex  
(Dako Canada, Inc.). Slides were washed again in PBS and 50 mM Tris buffer and then treated with 
3',3-diaminobenzidinetetrachloride (DAB 80 mg/72 uL of 30% hydrogen peroxide) in 400 mL 50 mM 
Tris buffer (pH 7.2). Finally, slides were rinsed in running tap water, counterstained with hematoxylin, 
rehydrated and coverslipped with Micromount medium (Surgipath Canada, Winnipeg, MB, Canada). 
Sections  were  stained  with  Mayer's  haematoxylin  and  eosin  Y  (H&E,  Armed  Forces  Institute  of 
Pathology, Washington, USA) for anatomical reference. Photographs were taken with an Axiophot 
Zeiss microscope (Germany) equipped with a digital camera.  
The specificity of the antibodies and their binding capacity in formaldehyde fixed tissues were 
determined using peptide absorption [18,19,24]. Negative controls were evaluated with the diluent 
solution  (Dako  Canada,  Inc.)  containing  15%  normal  swine  serum  substituted  for  the  primary 
antibody. Pre-absorption controls were prepared for all tissues tested. Peptides for mGluR 2/3, GluR 
2/3 and NMDAR 1 were custom synthesized by Quality Controlled Biochemical, Inc. (Hopkinton, 
MA) using the peptide sequences provided by Chemicon International Inc. Each peptide ranging from 
1.0 mg/mL to 0.004 mg/mL was incubated with the optimal concentration of the specific antibody at 
room temperature for 1 hour prior to placing the mixture on the slides. Rat brain slides at the level of 
the hippocampus were used as positive controls for the GluR antibodies.  
5.3. Primer Design 
Initial attempts to clone the glutamate receptors using primers based on the rat sequences were 
unsuccessful. This was speculated to be due to the: (1) low prevalence of GluRs, which then precludes 
cloning using total RNA and requires mRNA; and/or (2) the sequences of the GluRs from sea lions are 
sufficiently  dissimilar  to  those  from  rat.  Therefore,  a  search  for  evolutionary  relatedness  was 
performed. Based on mitochondrial gene sequences, Reyes et al. [28] concluded that Steller sea lions 
(Eumetopias jubatus) and dogs are related. Since both Californian and Steller sea lions belong to the Mar. Drugs 2010, 8                             
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family Otariidae, GluR sequences for several subtypes from the dog were included in alignments along 
with the cDNA sequences of the human, rat and mouse available from GenBank. The primers were 
designed using aligning (ClustalW2) dog, human, rat and mouse cDNA sequences.
 Three different 
primer sets (Table 1) were designed from various conserved domains. Sequences for Ka-2, GluR 2 and 
mGluR  5  were  obtained  and  compared  from  human,  dog  and  rat  and  were  assigned  the  following 
accession  numbers:  Ka-2-human  (accession  number-NM_002088);  dog  (accession  number-
XM_541594); rat (accession number NM_017262); GluR 2-human (accession number-NM_000827); rat 
(accession number NM_031608); Dog (accession number -XM_546286); mGluR 5-Human (accession  
number-NM_000842); rat (accession number-NM_017012), and dog (accession number-XP_856685). 
Due to inter-species sequence variability for NMDAR 1, primers based on rat sequences (accession 
number NM_017010) were used to amplify a product from sea-lion mRNA.  
5.4. PCR and Cloning 
The RT-PCR, PCR, and cloning methods have been previously described [24]. In brief, total RNA 
was  extracted  from  the  frozen  left  and  right  ventricles  using  the  Trizol  reagent  (Invitrogen,  
Burlington, ON, Canada) according
 to the manufacturer's instructions. RNA was dissolved in DEPC 
water and examined by spectrophotometric quantification (Nanodrop ND-1000 Spectrophotometer, 
Thermo Scientific).  
First  strand  cDNA  synthesis  was
 performed  by  using  the  Quantitect  Reverse  Transcription  Kit 
(Qiagen; Mississauga, ON, Canada). Several attempts were made to amplify gene fragments of the 
different subtypes of glutamate receptors including NMDAR 1, Ka-2, GluR 1, mGluR 5 and mGluR 2 
using three sets of primers (Table 1) for each subtype of GluRs. Conditions for amplifying glutamate 
receptors were optimized for the total RNA from the rat brain using a thermo-gradient (DNA Engine 
Peltier Thermal Cycler PTC-200, Bio-Rad Laboratories) from 52 ° C–62 ° C. PCR fragments were 
obtained  from  the  cDNA  made  from  the  total  RNA  from  rat  tissue  but  no  PCR  fragments  were 
visualized  using  total  RNA  extracted  from  sea  lion  hearts.  Thus  mRNA  was  extracted  using  the 
Oligotex kit (Qiagen Inc.) and RT-PCR and PCR were repeated using 100 ng of mRNA for the first 
strand  synthesis.  Using  mRNA,  PCR  products  successfully  obtained  and  the  appropriate  size 
fragments  were  extracted  using  Qiagen  gel  extraction  kit,  and  ligated  into  the  
PCR2.1-TOPO TA-cloning vector (Invitrogen Canada Inc.). The ligation mixture was transformed into 
competent cells of INVαF cells according
 to the manufacturer's instructions (Invitrogen Canada Inc.). 
Recombinant clones were extracted and these were analysed using double restriction digest with Not 1 
and BamH 1 flanking the PCR fragments.  
5.5. Sequencing of Clones 
Purified plasmid DNA (200–500 ng) was used as a template for cycle sequencing for animals Nos. 
3-6 (Big Dye Terminator v3.1, Applied Biosystems, Mississauga, ON, Canada) using the M13 forward 
and  reverse  primers.  Post-reaction  clean-up  was  performed  using  a  96  well  filter  binding  system 
(Montage SEQ96, Millipore, Etobicoke, ON) and fragments were resolved on an ABI 3130XL genetic 
analyzer running DNA Sequencing Analysis Software v5.2 (Applied Biosystems, Foster City, CA, 
USA). Individual sequencing runs were checked for quality using Sequencher v4.8 software (Gene Mar. Drugs 2010, 8                             
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Codes Corp. Ann Arbor, MI). Each plasmid was sequenced in both directions. The sequences were 
analysed  using  the  Basic  Local  Alignment  Search  Tool  (BLASTN)  from  the  National  Center  for 
Biotechnology Information (NCBI) centre.  
6. Conclusions 
In this study we have shown using both immunohistochemistry and molecular biology, a number of 
iGluRs and mGluRs including-mGluR 2/3, mGluR 5, GluR 2/3, NMDAR 1, Ka-2, GluR 1 and GluR 6 
were  all  expressed  in  the  sea  lion  hearts.  Since  these  receptors  were  present  in  the  heart  it  was 
hypothesized that the domoic acid maybe directly responsible for causing cardiomyopathy which has 
been observed in earlier studies. Although, the immunochemical localizations supports this hypothesis, 
the  expression  profiles,  due  to  the  inter-individual  variation,  does  not  conclusively  support  this 
hypothesis. Hence, further experiments with domoic acid treated animals need to be performed in 
order  to  confirm  the  hypothesis  that  degenerative  cardiomyopathy  could  be  due  to  the  direct 
interaction of domoic acid and the presence of glutamate receptors in the heart [16]. 
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